A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027)
Clinical trial NCT06772792 · COMPLETED
Trial details
- NCT number
- NCT06772792
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-23
- Primary completion
- 2024-06-21
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.